e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Exhaled biomarkers in children and adults with airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Calv,NO and J’awNO in asthma. A multidimensional approach
Raquel Lopez Reyes (Torrent (Valencia), Spain), Raquel Lopez-Reyes, Alberto Garcia-Ortega, Enrique Zaldivar, Miguel Perpiña Tordera
Source:
International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Session:
Exhaled biomarkers in children and adults with airways disease
Session type:
Poster Discussion
Number:
2098
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Raquel Lopez Reyes (Torrent (Valencia), Spain), Raquel Lopez-Reyes, Alberto Garcia-Ortega, Enrique Zaldivar, Miguel Perpiña Tordera. Calv,NO and J’awNO in asthma. A multidimensional approach. Eur Respir J 2015; 46: Suppl. 59, 2098
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
The multicomponent nature of difficult asthma
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Psychophysiology of depression in bronchial asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Lung function, FEno, symptoms and obesity in asthma – A cross-sectional study
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Clinical application of hydrogen sulfide (H2S) as a marker of asthma management
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Associated factors with persistent airflow limitation in asthma in U-BIOPRED
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Study of the small airway and its role in pediatric asthma control assessment
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Priorities for asthma R&D in Europe: A systematic approach
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Treating peripheral eosinophilia in asthma: Simple and effective
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept